Related Experiment Videos

Yersinia effector YopJ inhibits yeast MAPK signaling pathways by an evolutionarily conserved mechanism

Sara Yoon1, Zhengchang Liu, Yvonne Eyobo

  • 1Department of Molecular Biology, University of Texas Southwestern Medical School, Dallas 75390-9148, USA.

Insights

The Yersinia effector YopJ disrupts yeast MAP kinase pathways, similar to its action in mammals. This suggests a conserved mechanism regulating cell signaling across species.

Area of Science:

  • Microbiology
  • Cell Biology
  • Molecular Biology

Background:

  • Yersinia effector YopJ inhibits mammalian innate immunity by blocking MAP kinase (MAPK) and NF-kappaB signaling.
  • Understanding YopJ's mechanism in a simpler model organism can reveal conserved regulatory principles.

Purpose of the Study:

  • To investigate the effect of Yersinia effector YopJ on MAP kinase signaling pathways in Saccharomyces cerevisiae (yeast).
  • To determine if YopJ's inhibitory function in yeast is conserved compared to its known function in mammalian cells.

Main Methods:

  • Yeast strains were engineered to express Yersinia effector YopJ.
  • Specific MAP kinase pathways, including the pheromone response pathway and the high osmolarity growth (HOG) pathway, were analyzed.
  • The activation of key MAP kinases (Fus3p and Hog1p) was assessed in the presence of YopJ.

Main Results:

  • YopJ expression in yeast blocked the pheromone signaling pathway upstream of Fus3p activation in response to alpha factor.
  • YopJ also inhibited the HOG pathway upstream of Hog1p activation.
  • These findings indicate YopJ disrupts MAP kinase cascades in yeast.

Conclusions:

  • Yersinia effector YopJ interferes with yeast MAP kinase pathways, analogous to its effect on mammalian signaling.
  • This suggests a conserved, evolutionarily ancient mechanism for regulating signal transduction pathways by YopJ.
  • The study implicates a novel regulatory mechanism conserved across kingdoms for signal transduction.

Related Concept Videos